News & insights
AbbVie
Articles from Apotek Analytics.
-

FDA tentatively approves first generic lenacapavir. Zolgensma tumour cases shake gene therapy
HIV prevention moved closer to reach in poorer countries as the FDA gave tentative approval to the first generic lenacapavir.
-

FDA approves AbbVie’s first-in-class Parkinson’s pill as pharma deal-making accelerates
The FDA approved AbbVie’s tavapadon, branded Juvmo, for adults with Parkinson’s disease, as deal-making dominated the rest of the week.